Saturday, September 5, 2026
Home Authors Posts by Ogkologos

Ogkologos

4329 POSTS 0 COMMENTS

Adding Sintilimab to Chemoradiotherapy Improves Event-Free Survival in Patients with High-Risk...

Ogkologos -
0

EMA Recommends Granting a Marketing Authorisation for Sugemalimab

Ogkologos -
0

Significant Activity, Clinically Meaningful Functional and Symptomatic Improvements Observed in Patients...

Ogkologos -
0

Ivonescimab Plus Chemotherapy Significantly Improves PFS in Patients with NSCLC Previously...

Ogkologos -
0

FDA Grants Accelerated Approval to Selpercatinib for Paediatric Patients Two Years...

Ogkologos -
0

Cross-Border Network of European Specialists Provides New Treatment Options For Women...

Ogkologos -
0

Asciminib Shows Superior Efficacy Over Investigator-Selected TKIs and Imatinib in Patients...

Ogkologos -
0

ESMO Gastrointestinal Cancers Congress 2024 Munich, Germany, 26-29 June

Ogkologos -
0

First-Line 177Lu-Dotatate Plus Octreotide LAR Significantly Extends PFS in Patients with...

Ogkologos -
0

Neoadjuvant Nivolumab Plus Ipilimumab Leads to a Pathological Response in a...

Ogkologos -
0
1...727374...433Page 73 of 433

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com